Healthpeak's top-line expansion, fueled by the Physicians Realty Trust merger and life science development, drove 11.1% revenue growth in Q2 2026, yet the sharp swing to -$394.8M AFFO and a 60.7% FFO payout ratio signal cash flow strain. The balance sheet rema...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue grew 11.1% year-over-year to $771.6M in Q2 2026, but NOI margin volatility (swinging from 60.2% to -20.0% in Q1 2026) and negative AFFO of -$394.8M indicate integration costs and non-cash charges distorting profitability.
Healthpeak Properties owns approximately 700 properties, focusing on medical office buildings and life science assets. This diversification provides stability through various market cycles.
The company has new development projects totaling $148 million, with around 80% pre-leased. These projects are expected to yield mid-single-digit returns upon stabilization, indicating potential for solid revenue growth.
Healthpeak plans to sell over $1 billion in outpatient assets to reinvest in higher-return lab and development opportunities. This strategy aims to enhance overall portfolio returns.
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 4, 2026 | $0.08+184.2% vs $0.03 | $750M+3.3% vs $726M |
Q2 2026 May 5, 2026 | $0.28+430.7% vs $0.05 | $739M+6.4% vs $695M |
Q1 2026 Feb 2, 2026 | $0.16-64.4% vs $0.45 | $705M+1.9% vs $692M |
Q4 2025 Oct 23, 2025 | -$0.17-383.3% vs $0.06 | $690M+0.5% vs $687M |
Healthpeak gets its prior buy from Oct. 2025 reaffirmed. Positives include a supportive macro environment, dividend coverage and high yield, an investment-grade rating, and leasing growth in Q2. Selective diversification is spread across outpatient, lab, and senior housing across a geographically diverse scale.
Five S&P 500 stocks—VICI, PFE, VZ, T, F—offer 'safer' high yields, with free cash flow covering dividends and dividends from $1K invested exceeding share prices. Analyst projections indicate the top ten S&P 500 dividend dogs could deliver average net gains of 24.11% by September 2027, with risk/volatility 36% below the market. Dividend dog strategy favors contrarian buys on price pullbacks; most top-yielding stocks become attractive as market corrections bring yields in line with share prices.
Hsbc Holdings PLC decreased its holdings in Healthpeak Properties, Inc. (NYSE: DOC) by 12.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,952,394 shares of the real estate investment trust's stock after selling 431,633 shares during the period. Hsbc
Healthpeak (DOC) reported earnings 30 days ago. What's next for the stock?
Benchmark DOC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Healthpeak Properties, Inc. (DOC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $20.48 | $14.12B | 204.80 | 4.52% | 2.53% | 0.82% | 5.96% | |
| $86.64 | $42.12B | 160.44 | 18.47% | 4.13% | 1.99% | — | |
| $229.94 | $165.69B | 165.42 | 35.82% | 10.67% | 3.08% | — | |
| $17.96 | $6.3B | -25.30 | -6.92% | -7.59% | -1.91% | — | |
| $46.17 | $13.75B | 23.80 | 13.95% | 66.43% | 15.76% | — | |
| $2.19 | $865.74M | 1.63 | -8.54% | 25.14% | — | — |
Healthpeak Properties, Inc. (DOC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Healthpeak Properties, Inc. (DOC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 4, 2026·SEC
May 5, 2026·SEC
May 4, 2026·SEC
Get notified when DOC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Healthpeak Properties, Inc. (DOC) stock FAQ — growth, dividends, profitability & financials explained
Healthpeak Properties, Inc. (DOC) reported $2.95B in revenue for fiscal year 2025. This represents a 74% increase from $1.69B in 2011.
Healthpeak Properties, Inc. (DOC) grew revenue by 4.5% over the past year. Growth has been modest.
Yes, Healthpeak Properties, Inc. (DOC) is profitable, generating $253.7M in net income for fiscal year 2025 (2.5% net margin).
Yes, Healthpeak Properties, Inc. (DOC) pays a dividend with a yield of 5.96%. This makes it attractive for income-focused investors.
Healthpeak Properties, Inc. (DOC) has a return on equity (ROE) of 0.8%. This is below average, suggesting room for improvement.
Healthpeak Properties, Inc. (DOC) generated Funds From Operations (FFO) of $1.35B in the trailing twelve months. FFO is the primary profitability metric for REITs.
Healthpeak Properties, Inc. (DOC) offers a 5.96% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.
